| Global Pharmaceuticals Research & Manufacturing |
| |
| 03-04 Dec 2008 Hotel J W Marriott |
| |
| • 尋找在印度進行臨床實驗外包的方法。 |
| • 世界上製藥業界目前商業模式中，考慮印度研究製造業務委託服務（CRAMS）/醫藥品販賣業務受託機關(CSO)優點活用的方法。 |
| • 針對將國際性的研究開發業務移轉至印度的意義，進行討論。 |
| • 檢討印度的醫藥品市場上的生物科技企業之影響力與貢獻度。 |
| • 理解企業間的提攜或協力之革新商業模式。 |
| |
| Key Note Speakers |
 |
|
 |
|
 |
|
 |
|
 |
Mr Suhas
Chaudhari
Joint
Commissioner
(Greater Mumbai)
FDA
Maharashtra State |
|
Mr Ranga Iyer
President OPPI and
Managing
Director
Wyeth |
|
Uma Nandan
Misra
Vice President
-Operations &
Site Manager
AstraZeneca Pharma |
|
Mr Ranjit Shahani
Vice Chairman
Managing
Director
and Country President
Novartis |
|
Mr Harjit
Singh
Senior
Development
Manager
Takeda Global Research
and
Development
UK |
|
| |
| |
| Top Level Speakers from |
| Abbott India |
Actis Biologics |
| All India Institute of
Medical Sciences |
Amgen India |
| AstraZeneca Pharma |
Aventis Pharma |
| Cadila Pharmaceuticals |
Dr Reddy's Laboratories |
| Eisai India |
Eli Lilly &Co. |
| Evolva Biotech |
FDA Maharashtra State |
| GlaxoSmithKline
Pharmaceuticals |
Institute of Clinical
Research India |
| Nishith Desai Associates |
Novartis |
| Nycomed Pharma USA |
Pfizer |
| Sandoz |
Takeda Global Research
and Development |
| USV |
Wockhardt |
| Wyeth |
Zydus Cadila |
|
| |
| 参加對象業界 |
• Pharmaceutical Companies |
• Biotech Companies |
• CROs and CMOs |
• Pharmaceutical Manufacturers |
• Research Laboratories and Institutes |
• Business Consulting Firms |
• Government Institutions and Regulators |
• Private Equity Funds |
• Venture Capitalists |
| |
| |
| 参加對象者 |
The Global Pharmaceuticals conference has been
developed with the following executives in mind: |
| • CXOs |
| • Project Directors |
| |
| |
